1724 results for Treatments
Refine Your Search
The Future of CML Treatment: What’s Next?
Education Resources
FDA Approves Combination Treatment for Multiple Myeloma
Blood Cancer United has played a role in supporting the foundational research that paved the way for this approval. Over more than a decade, we have …
News Release
Choosing a Blood Cancer Specialist or a Treatment Center
Taking an active role in making decisions regarding your treatment can have a positive effect on your health and quality of life. One of your first ch…
AML and Children: Understanding Diagnosis and Treatment
Dr. Katherine Tarlock, a pediatric hematology expert from Seattle Children’s Hospital briefly discusses AML and its prevalence in children. She will d…
Emerging Research and Promising AML Treatment Approaches
Topics Covered We invite you to learn more about: AML treatment news released at ASH How these novel agents will be used in clinics Genetic pr…
Paying for your child's blood cancer treatment
It is important to understand your expenses and have a plan to manage them during and after a child’s blood cancer diagnosis.
Support Resources
FDA Approves Treatment for Myelofibrosis and Anemia
RYE BROOK, N.Y., September , – The U.S. Food and Drug Administration (FDA) recently approved momelotinib (Ojjaara™) for use in adults with intermedia…
News Release
The Future of Myeloma Treatment: What’s Next?
Topics CoveredWe invite you to learn more about:Current myeloma treatmentsWhat the future holds for myeloma management …
News Release
The Future of Myeloma Treatment: What’s Next?
Education Resources
What Are the Current Treatment Options for AML?
Topics Covered We invite you to learn more about: An overview of current treatment options, including chemotherapy, targeted therapy and treatment…
Bispecific Therapy: Advancing Patient Care through Targeted Treatment
This activity is intended for physicians, physician assistants/associates, and nurses engaged in the care of patients with hematologic malignancies.
Education Resources
Long-term and late effects of blood cancer treatment
effects can linger for months or years after therapy. Heart disease and other cancers can appear years after treatment.
Support Resources
Types of blood cancer treatment for young adults
Chemotherapy, stem cell transplantation, and radiation therapy are common blood cancer treatments, but disease type and risk factors also determine th…
Support Resources
Choosing a pediatric blood cancer specialist or treatment center
After your child receives a blood cancer diagnosis, you will want to find a blood cancer specialist or choose a treatment center. Here’s how.
Support Resources
Schooling children and teens during blood cancer treatment
Virtual, inpatient, and homebound learning are available to help your child continue their education while undergoing treatment for blood cancer.
Support Resources
Making blood cancer treatment decisions for young adults
Learn how to get a second opinion and what questions to ask your blood cancer care team before you move forward with a treatment plan.
Support Resources
Making blood cancer treatment decisions for your child
Learn how to get a second opinion and what questions to ask your child's blood cancer care team before you decide on a treatment plan.
Support Resources
Myelodysplastic Syndromes: Diagnosis, Treatment, and Side Effect Management
This activity is intended for oncology nurse practitioners, nurses, and social workers involved in the care of patients with myelodysplastic syndromes…
Education Resources
Genetic pathways of myeloid transformation and treatment response
Our central goal is to improve clinical outcomes in patients with myeloid malignancies through developing an enhanced mechanistic understanding of dis…
FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma
The Food and Drug Administration (FDA) has approved a new treatment, teclistamab (Tecvayli), for adults with multiple myeloma that has returned or con…
News Release